New Developments in Immune Thrombocytopenia: Expert Insights to Guide Clinical Practice

Learn how experts provide optimal care of patients with ITP through guideline recommendations and their clinical experience through a focused expert-authored commentary with insights on the latest clinical data. Download the ITP Interactive Decision Support Tool to tailor your treatment decisions to individual patients.

Share

Program Content

Activities

ITP Management
Managing Immune Thrombocytopenia: Latest Insights and a New Interactive Decision Support Tool
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: October 18, 2022

Expires: October 17, 2023

Activities

ITP Decision Support Tool
Interactive Decision Support Tool: Expert Treatment Guidance for ITP
Tool
Congratulations: You achieved a completion on 04/09/2022

Released: October 26, 2022

Expires: October 25, 2023

Faculty

cover img faculity

Hanny Al-Samkari, MD

Classical Hematologist and Clinical Investigator
The Peggy S. Blitz Endowed Chair in Hematology/Oncology
Co-Director, Hereditary Hemorrhagic Telangiectasia Center
Massachusetts General Hospital
Associate Professor of Medicine
Harvard Medical School
Boston, Massachusetts

cover img faculity

Hanny Al-Samkari, MD

Assistant Professor
Harvard Medical School
Attending Hematologist and Clinical Investigator
Division of Hematology Oncology
Massachusetts General Hospital
Boston, Massachusetts

cover img faculity

Catherine M. Broome, MD

Professor of Medicine
Director of Cellular Apheresis
Lombardi Cancer Center
MedStar Georgetown University
Washington, DC

cover img faculity

Sandhya Ramanathan Panch, MD, MPH

Associate Professor
Division of Hematology
University of Washington
Medical Director
Transfusion Services
Fred Hutchinson Cancer Center
Seattle, Washington

cover img faculity

Kristin Ammon Shimano, MD

Health Sciences Clinical Associate Professor
Department of Pediatrics
UCSF Benioff Childrens Hospital
San Francisco, California

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Novartis Pharmaceuticals Corporation

Rigel Pharmaceuticals Inc